Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

Validation of Non-Invasive Hemoglobin Measurement Using Optical Method for Anemia Screening Among Adults in Jakarta (SPECTRO-Hb)

13. července 2026 aktualizováno: Yohanes Firmansyah, dr, MH, MM, Tarumanagara University

Validation of Non-Invasive Hemoglobin Measurement (Using Optical Method) Compared With Point-of-Care Testing and Hematology Analyzer Among Adult in Jakarta

Anemia remains a major public health concern and is commonly diagnosed through hemoglobin measurement using capillary or venous blood samples. Although laboratory-based and point-of-care testing methods are widely used, they require blood collection, trained personnel, and may cause discomfort to participants. Non-invasive spectrophotometric technology has emerged as a potential alternative for rapid hemoglobin assessment without blood sampling.

This study aims to evaluate the validity and diagnostic performance of a non-invasive hemoglobin using optical method compared with capillary point-of-care testing (POCT) and venous blood hemoglobin measured using an automated hematology analyzer as the reference standard. A total of 150 adults from Kelurahan Kota Bambu, Jakarta, will undergo non-invasive hemoglobin measurement, capillary blood testing, and venous blood testing during a single study visit.

The study will assess agreement between methods, diagnostic accuracy for anemia detection, and factors that may influence measurement performance. Findings from this study are expected to support the development of convenient, community-based anemia screening strategies and provide evidence for future implementation of non-invasive hemoglobin assessment technologies.

Přehled studie

Postavení

Zatím nenabíráme

Podmínky

Detailní popis

Background

Anemia affects billions of people worldwide and remains an important public health challenge, particularly in low- and middle-income countries. Undiagnosed anemia is associated with impaired physical performance, reduced productivity, cognitive dysfunction, poor maternal outcomes, and increased morbidity. Early detection of anemia is therefore essential for timely intervention and prevention of complications.

Conventional hemoglobin measurement relies on venous blood analysis using automated hematology analyzers or capillary blood testing using point-of-care devices. While these methods provide reliable results, they require blood collection, trained healthcare personnel, consumable materials, and appropriate laboratory infrastructure. In addition, invasive sampling may cause pain, anxiety, and reluctance to participate in large-scale screening programs.

Recent advances in optical and spectrophotometric technologies have enabled the development of non-invasive methods for estimating hemoglobin concentration without blood collection. These systems utilize light absorption and reflection characteristics of peripheral tissues to estimate hemoglobin levels rapidly and painlessly. Non-invasive approaches may improve participant acceptance, facilitate repeated measurements, and support large-scale community screening initiatives. However, their accuracy and agreement with established laboratory methods remain variable across populations and settings. Therefore, local validation studies are necessary before widespread implementation.

Objectives

Primary Objective

To evaluate the validity and agreement of a non-invasive hemoglobin measurement method compared with capillary POCT hemoglobin measurement and venous blood hemoglobin measured using an automated hematology analyzer.

Secondary Objectives

To determine the correlation between non-invasive hemoglobin measurements and hematology analyzer results.

To assess agreement between non-invasive measurements, POCT results, and hematology analyzer measurements using Bland-Altman analysis.

To evaluate the sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratios, and diagnostic accuracy for anemia detection.

To explore the feasibility of implementing non-invasive hemoglobin measurement in community-based screening programs.

Study Design

This study is a community-based cross-sectional diagnostic validation study.

Study Population

The study population consists of adults aged 18 years and older participating in community health screening activities in Kelurahan Kota Bambu, Jakarta.

Sample Size

A total of 150 participants will be recruited using consecutive sampling. Sample size calculation was based on an expected diagnostic accuracy of 90%, a confidence level of 95%, and a margin of error of 5%, with additional participants included to compensate for incomplete data.

Study Procedures

Each participant will undergo three hemoglobin measurements during a single study visit:

Non-Invasive Hemoglobin Measurement Performed on the thumb using a using optical method device. No blood collection is required. Capillary Hemoglobin Measurement Obtained through finger-prick blood sampling. Measured using a point-of-care testing (POCT) device. Venous Hemoglobin Measurement Venous blood collected by trained healthcare personnel. Analyzed using an automated hematology analyzer as the reference standard.

Demographic information, medical history, smoking status, anthropometric measurements, and factors potentially affecting measurement accuracy will also be collected.

Outcome Measures

Primary Outcome

Agreement between non-invasive hemoglobin measurements and venous hemoglobin measured using a hematology analyzer.

Secondary Outcomes

Correlation coefficients between methods. Mean measurement bias and limits of agreement. Sensitivity and specificity for anemia detection. Positive and negative predictive values. Likelihood ratios. Area under the receiver operating characteristic (ROC) curve. Cohen's kappa coefficient for anemia classification agreement. Statistical Analysis

Descriptive statistics will summarize participant characteristics and hemoglobin measurements. Agreement between methods will be assessed using Bland-Altman analysis and Intraclass Correlation Coefficients (ICC). Correlation analyses will be conducted using Pearson or Spearman tests as appropriate. Diagnostic performance will be evaluated through sensitivity, specificity, predictive values, likelihood ratios, ROC analysis, and area under the curve (AUC). Cohen's kappa coefficient will assess agreement in anemia classification. Subgroup analyses may be performed according to age, sex, and measurement conditions.

Expected Impact

The study is expected to provide evidence regarding the accuracy and screening capability of non-invasive hemoglobin measurement in community settings. Results may contribute to the development of accessible, rapid, and patient-friendly anemia screening programs and support future research involving pediatric and other vulnerable populations.

Typ studie

Pozorovací

Zápis (Odhadovaný)

200

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní kontakt

Studijní záloha kontaktů

Studijní místa

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

  • Dospělý
  • Starší dospělý

Přijímá zdravé dobrovolníky

Ano

Metoda odběru vzorků

Vzorek nepravděpodobnosti

Studijní populace

Adults aged 18 years and older participating in community-based health screening activities in Jakarta. Participants include both healthy individuals and individuals with potential anemia or other underlying medical conditions. All participants undergo non-invasive hemoglobin measurement, capillary hemoglobin testing using POCT, and venous blood hemoglobin measurement using an automated hematology analyzer during a single study visit.

Popis

Inclusion Criteria:

  • Adults aged 18 years and older.
  • Residents or community members participating in community health screening activities in Kelurahan Kota Bambu, Jakarta.
  • Willing to undergo non-invasive hemoglobin measurement.
  • Willing to undergo capillary blood hemoglobin testing using point-of-care testing (POCT).
  • Willing to undergo venous blood collection for hematology analyzer examination.
  • Able to provide written informed consent.

Exclusion Criteria:

  • Active bleeding at the time of examination.
  • Severe acute illness requiring urgent medical attention.
  • Refusal to undergo finger-prick or venous blood sampling.
  • History of severe anxiety, syncope, or adverse reactions related to blood collection procedures.
  • Visible infection, wound, or skin lesion at the measurement site.
  • Severe hand deformity preventing proper non-invasive measurement.
  • Nail polish or artificial nails that cannot be removed before examination.
  • Markedly cold hands or poor peripheral perfusion that may interfere with optical measurements.
  • Incomplete hemoglobin measurement data from any of the study methods.

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

Kohorty a intervence

Skupina / kohorta
Diagnostic Validation Cohort
A cohort of 200 adults recruited from community screening activities. Each participant undergoes three hemoglobin assessments: non-invasive hemoglobin measurement, capillary blood hemoglobin measurement using POCT, and venous blood hemoglobin measurement using an automated hematology analyzer as the reference standard. Data are used to evaluate agreement, diagnostic accuracy, and anemia classification performance of the non-invasive measurement method.

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Agreement Between Non-Invasive Hemoglobin Measurement and Hematology Analyzer
Časové okno: Day 1
Assessment of agreement between non-invasive hemoglobin values and venous hemoglobin values measured using an automated hematology analyzer using Bland-Altman analysis, mean bias, 95% limits of agreement, and intraclass correlation coefficient (ICC).
Day 1
Diagnostic Accuracy for Anemia Detection
Časové okno: Day 1
Diagnostic performance of non-invasive hemoglobin measurement for identifying anemia compared with hematology analyzer results, including sensitivity, specificity, positive predictive value, negative predictive value, and overall diagnostic accuracy.
Day 1

Sekundární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Correlation Between Non-Invasive Hemoglobin Measurement and Hematology Analyzer
Časové okno: Day 1
Hemoglobin concentration obtained from the non-invasive device will be compared with venous hemoglobin concentration measured using a laboratory hematology analyzer. The strength and direction of the relationship will be quantified using Pearson's correlation coefficient for normally distributed data or Spearman's rank correlation coefficient for non-normally distributed data. Correlation coefficients (r), 95% confidence intervals, and p-values will be reported.
Day 1
Agreement Between Non-Invasive Hemoglobin Measurement and Point-of-Care Testing
Časové okno: Day 1
Hemoglobin concentration obtained from the non-invasive device will be compared with capillary hemoglobin concentration measured using a point-of-care testing (POCT) device. Agreement will be evaluated using Bland-Altman analysis, including mean bias and 95% limits of agreement. Intraclass correlation coefficients (ICC) with 95% confidence intervals will also be calculated to assess measurement reliability between methods.
Day 1
Area Under the ROC Curve (AUC) for Anemia Detection
Časové okno: Day 1
The diagnostic performance of the non-invasive hemoglobin measurement device for identifying anemia will be evaluated using receiver operating characteristic (ROC) curve analysis, with venous hemoglobin concentration measured by a hematology analyzer serving as the reference standard. The area under the ROC curve (AUC), optimal cutoff value, sensitivity, specificity, positive predictive value, and negative predictive value will be reported.
Day 1
Agreement in Anemia Classification
Časové okno: Day 1
Participants will be classified as anemic or non-anemic based on established hemoglobin thresholds. Agreement between anemia classifications derived from non-invasive hemoglobin measurements and venous hemoglobin measurements obtained using a hematology analyzer will be assessed using Cohen's kappa coefficient. Kappa values and corresponding 95% confidence intervals will be reported.
Day 1

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Vyšetřovatelé

  • Ředitel studie: Alexander Halim Santoso, Tarumanagara University

Publikace a užitečné odkazy

Osoba odpovědná za zadávání informací o studiu tyto publikace poskytuje dobrovolně. Mohou se týkat čehokoli, co souvisí se studiem.

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia (Odhadovaný)

11. července 2026

Primární dokončení (Odhadovaný)

30. července 2027

Dokončení studie (Odhadovaný)

30. července 2028

Termíny zápisu do studia

První předloženo

8. července 2026

První předloženo, které splnilo kritéria kontroly kvality

8. července 2026

První zveřejněno (Aktuální)

14. července 2026

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

15. července 2026

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

13. července 2026

Naposledy ověřeno

1. července 2026

Více informací

Termíny související s touto studií

Plán pro data jednotlivých účastníků (IPD)

Plánujete sdílet data jednotlivých účastníků (IPD)?

NEROZHODNÝ

Popis plánu IPD

IPD Sharing Description De-identified individual participant data underlying the results reported in publications may be shared upon reasonable request to the principal investigator, following approval by the institutional ethics committee and execution of an appropriate data-sharing agreement.

Supporting Information Study protocol, statistical analysis plan, and data dictionary.

Time Frame Beginning 6 months after publication and ending 5 years after publication.

Access Criteria Access will be granted to qualified researchers for scientifically sound research proposals, subject to ethical approval and institutional review.

Informace o lécích a zařízeních, studijní dokumenty

Studuje lékový produkt regulovaný americkým FDA

Ne

Studuje produkt zařízení regulovaný americkým úřadem FDA

Ne

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .

Předplatit